HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

6- (5- ((cyclopropylamino)carbonyl)- 3- fluoro- 2- methylphenyl)- N- (2,2- dimethylprpyl)- 3- pyridinecarboxamide

structure in first source
Also Known As:
GSK-AHAB; GW856553; losmapimod
Networked: 36 relevant articles (10 outcomes, 20 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Sprecher, Dennis L: 6 articles (08/2020 - 02/2011)
2. Sarov-Blat, Lea: 6 articles (09/2014 - 02/2011)
3. Willette, Robert N: 4 articles (08/2020 - 09/2009)
4. Cheriyan, Joseph: 4 articles (01/2018 - 02/2011)
5. Lepore, John J: 4 articles (04/2016 - 02/2011)
6. Cavender, Matthew A: 3 articles (01/2022 - 05/2015)
7. Morrow, David A: 3 articles (01/2022 - 05/2015)
8. O'Donoghue, Michelle L: 3 articles (01/2022 - 05/2015)
9. Sabatine, Marc S: 3 articles (01/2022 - 05/2015)
10. Wilkinson, Ian B: 3 articles (01/2018 - 02/2011)

Related Diseases

1. Chronic Obstructive Pulmonary Disease (COPD)
2. Neuralgia (Stump Neuralgia)
3. ST Elevation Myocardial Infarction
4. Myocardial Infarction
5. Peripheral Nerve Injuries

Related Drugs and Biologics

1. 6- (5- ((cyclopropylamino)carbonyl)- 3- fluoro- 2- methylphenyl)- N- (2,2- dimethylprpyl)- 3- pyridinecarboxamide
2. Analgesics (Analgesic Drugs)
3. p38 Mitogen-Activated Protein Kinases
4. Interleukin-1beta (Interleukin 1 beta)
5. Protein Isoforms (Isoforms)
6. Salts
7. Renin
8. Aldosterone
9. Fibrinogen (Factor I)
10. Methotrexate (Mexate)

Related Therapies and Procedures

1. Duration of Therapy
2. Therapeutics
3. Analgesia